We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $829M invested in Intra-Cellular Therapies Inc. in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more capital invested
Capital invested by funds: $553M → $829M (+$276M)
47% more call options, than puts
Call options by funds: $30.8M | Put options by funds: $21M
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
0% more funds holding
Funds holding: 131 → 131 (0)
13% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 47
Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
41
Reduced
47
Closed
19
Calls
$30.8M
Puts
$21M
Net Calls
+$9.81M
Net Calls Change
+$5.83M
Top Buyers
| 1 |
PC
PointState Capital
New York
|
+$36.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.9M |
| 4 |
DFO
Duquesne Family Office
New York
|
+$5.79M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.69M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$17.2M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$8.82M |
| 3 |
SC
Samlyn Capital
New York
|
-$6.83M |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$5.69M |
| 5 |
BlackRock
New York
|
-$4.87M |
